ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING

Center for Label-free Imaging and Multiscale Biophotonics (CLIMB)

Active
Institution
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL
Principal investigator
Stephen A Boppart
Funding
$1.1M
Duration
2022–2027
Open portfolio

Moonbase score

Still being scored

Abstract

SUMMARY The Center for Label-free Imaging and Multiscale Biophotonics (CLIMB) develops cutting-edge optical and computational imaging technologies for addressing grand challenges in biomedicine, including cancer and neurodegenerative diseases. Building upon the recent advances in interferometric, nonlinear, chemical, and computational imaging at UIUC, CLIMB will establish a unique technology and training hub for cutting-edge biophotonics. Specifically, the three Technology Research and Development (TRD) projects will synergize expertise in multimodal and nonlinear imaging from the Boppart group, computational imaging from the Anastasio group, and quantitative phase imaging, from the Popescu group, to translate new technology from lab-to-clinic and point-of-care settings. The unifying concept for the technologies developed at CLIMB is the ability to extract quantitative biomarkers from specimens using intrinsic contrast imaging, i.e., label-free. These technologies will be pushed for the first time to handheld configurations to allow in-vivo and point-of-care (POC) operation. We developed a rigorous and inclusive technology training and dissemination plan, as well as a comprehensive educational program to prepare the next generation of biophotonics researchers for excelling in label-free imaging.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGP41ZEB1-OSR-F(M2)Pimagingnonlinearmultiscalepoint-of-caretrdtraining disseminationlabel-freehandheld

Questions for UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.